Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Ascites and oedema

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Infected, tense or organ-threatening fluid

Ascites with sepsis, new encephalopathy, gastrointestinal bleeding, shock or kidney injury may represent spontaneous bacterial peritonitis or decompensated cirrhosis. Rapidly increasing abdominal pressure, severe dyspnoea, anuria, unilateral swollen leg or spreading skin infection also needs urgent assessment.

Action: Use ABCDE assessment, obtain observations, glucose, intravenous access and urgent bloods, and perform prompt diagnostic paracentesis before antibiotics when this causes no harmful delay. Treat sepsis and decompensation under the local pathway, assess venous thrombosis or cellulitis, and use monitored drainage when pressure itself is compromising breathing or comfort.

Synopsis

Assess fluid by mechanism, recognise emergencies, relieve pressure safely and choose drainage, diuretics, compression or skin care according to cause, monitoring burden and goals.

  • Ascites is free peritoneal fluid; peripheral oedema is interstitial fluid. Both are signs with malignant, portal-hypertensive, cardiac, renal, venous, lymphatic, drug and low-albumin causes.
  • First-line assessment establishes onset, breathlessness, pain, fever, urine output, weight trend, medicines, liver and cardiac signs, unilateral versus bilateral swelling and the desired outcome.
  • Urgently assess fever with abdominal pain, shock, new encephalopathy, oliguria, rapidly worsening dyspnoea, unilateral painful swelling or threatened skin.
  • Ultrasound confirms and maps ascites before drainage; new, unexplained or clinically changed fluid usually needs diagnostic paracentesis when the result will alter care.
  • The serum-ascites albumin gradient supports mechanism: 11 g/L or more favours portal hypertension, whereas a lower gradient favours peritoneal disease, but interpret in clinical context.
  • Therapeutic paracentesis is first-line for rapid relief of tense, symptomatic malignant ascites; repeated procedures or a tunnelled catheter may suit recurrent fluid.
  • In cirrhotic ascites, sodium moderation, spironolactone with or without furosemide and carefully monitored paracentesis follow a different pathway; give albumin after more than 5 litres according to the cirrhosis protocol.
  • Diuretics are less predictably effective in pure peritoneal carcinomatosis and more likely to help when portal hypertension, heart failure or renal sodium retention contributes.
  • Compression is not an automatic treatment for every swollen leg: first exclude acute DVT, severe arterial disease, decompensated heart failure, infection and fragile or leaking skin.
  • The gold-standard plan names the mechanism, target symptom, expected time to benefit, biochemical and weight limits, escalation route and explicit stop point.

Key red flags

Fever, abdominal tenderness, new confusion, hypotension or rising creatinine with ascites suggests infected fluid even when pain is mild.

Severe breathlessness, hypoxia or inability to lie flat may reflect tense ascites, pleural fluid, pulmonary oedema or embolism and needs cause-focused assessment.

New oliguria, postural collapse, hyponatraemia or rapid creatinine rise may follow intravascular depletion despite visible oedema.

Unilateral painful leg swelling, chest pain or haemoptysis raises venous thromboembolism and should not be treated simply with elevation or compression.

Red, hot, tender or blistering oedematous skin suggests cellulitis, necrosis or severe pressure injury.

New ascites with weight loss, a pelvic mass or altered bowel habit requires diagnostic evaluation if disease-directed treatment remains an option.

Rapid diuretic escalation without renal, sodium, potassium, blood-pressure and weight review can precipitate encephalopathy, arrhythmia and kidney injury.

Spontaneous bacterial peritonitis

Abdominal pain, fever, hypotension, encephalopathy or renal decline in cirrhotic ascites requires urgent diagnostic tap and antibiotics.

Investigation priorities

01
First-line bedside assessmentFirst stepFirst line

Define observations, perfusion, weight trend, girth, jugular pressure, lungs, abdominal tension, pitting distribution, skin and unilateral features.

Management branches

Immediate assessmentExclude infection and organ compromise

Ascites or oedema is new, rapidly worse, painful, febrile or associated with breathlessness, confusion or oliguria.

  1. Assess ABCDE, sepsis, respiratory effect, perfusion, urine output, unilateral leg signs and skin; clarify escalation wishes without delaying immediate comfort.
  2. Obtain urgent bloods and ultrasound and perform diagnostic paracentesis promptly in cirrhosis or suspected peritonitis when safe; investigate DVT or cardiac failure as indicated.
  3. Treat infection, thrombosis or decompensated organ failure within goals and use monitored therapeutic drainage when pressure is causing severe symptoms.

Key medicines

Spironolactone for portal-hypertensive ascitesA common cirrhosis regimen starts at 100 mg orally daily and titrates at intervals toward 400 mg if required; frail palliative patients often need a lower individual start under local hepatology guidance.Monitor potassium, sodium, creatinine, blood pressure and weight; avoid or pause in severe hyperkalaemia, progressive kidney injury or symptomatic volume depletion and review interacting medicines.
Furosemide with spironolactoneFor recurrent or severe cirrhotic ascites, a common paired start is furosemide 40 mg with spironolactone 100 mg orally daily, titrated in the same 40:100 ratio under protocol.Over-diuresis causes hypovolaemia, hyponatraemia, hypokalaemia, kidney injury, gout and encephalopathy; ototoxicity is a concern with high or rapid intravenous dosing.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG50 cirrhosis in over 16sRecognition and management of decompensated cirrhosis, ascites and infection.
  • BSG and BASL ascites guidelineDiagnostic paracentesis, diuretic regimens, weight targets, albumin and refractory ascites.
  • Scottish Palliative Care Guidelines: ascitesPalliative assessment, malignant drainage and symptom-focused planning.
  • BNF spironolactone monographDosing, renal and electrolyte cautions and interactions.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom